Articles with public access mandates - James M. HoffmanLearn more
Not available anywhere: 7
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza
AH Gaur, B Bagga, S Barman, R Hayden, A Lamptey, JM Hoffman, ...
New England journal of medicine 362 (1), 88-89, 2010
Mandates: US National Institutes of Health
National survey on the effect of oncology drug shortages on cancer care
A McBride, LM Holle, C Westendorf, M Sidebottom, N Griffith, RJ Muller, ...
American journal of health-system pharmacy 70 (7), 609-617, 2013
Mandates: US National Institutes of Health
Biomedical data science and informatics challenges to implementing pharmacogenomics with electronic health records
JM Hoffman, AJ Flynn, JE Juskewitch, RR Freimuth
Annual Review of Biomedical Data Science 3 (1), 289-314, 2020
Mandates: US National Institutes of Health
Implications of the FDA draft guidance on biosimilars for clinicians: what we know and don't know
E Li, JM Hoffman
Journal of the National Comprehensive Cancer Network 11 (4), 368-372, 2013
Mandates: US National Institutes of Health
Pharmacogenomics implementation: “a little less conversation, a little more action, please”
KE Caudle, JM Hoffman, RS Gammal
Pharmacogenomics 24 (4), 183-186, 2023
Mandates: US National Institutes of Health
Preventing chemotherapy errors: Updating guidelines to meet new challenges
BR Goldspiel, R DeChristoforo, JM Hoffman
American Journal of Health-System Pharmacy 72 (8), 668-669, 2015
Mandates: US National Institutes of Health
Leveraging precision medicine to mitigate medication-safety challenges
RS Gammal, JM Hoffman
American Journal of Health-System Pharmacy 74 (24), 2031-2032, 2017
Mandates: US National Institutes of Health
Available somewhere: 56
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ...
Genetics in Medicine 19 (2), 215-223, 2017
Mandates: US National Institutes of Health
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers
HM Dunnenberger, KR Crews, JM Hoffman, KE Caudle, U Broeckel, ...
Annual review of pharmacology and toxicology 55 (1), 89-106, 2015
Mandates: US National Institutes of Health
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
KE Caudle, TE Klein, JM Hoffman, DJ Müller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
The second victim experience and support tool: validation of an organizational resource for assessing second victim effects and the quality of support resources
JD Burlison, SD Scott, EK Browne, SG Thompson, JM Hoffman
Journal of patient safety 13 (2), 93-102, 2017
Mandates: US National Institutes of Health
PG4KDS: a model for the clinical implementation of pre‐emptive pharmacogenetics
JM Hoffman, CE Haidar, MR Wilkinson, KR Crews, DK Baker, ...
American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2014
Mandates: US National Institutes of Health
The clinical pharmacogenetics implementation consortium: 10 years later
MV Relling, TE Klein, RS Gammal, M Whirl‐Carrillo, JM Hoffman, ...
Clinical Pharmacology & Therapeutics 107 (1), 171-175, 2020
Mandates: US National Institutes of Health
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ...
Cell 185 (4), 603-613. e15, 2022
Mandates: US National Institutes of Health, Australian Research Council, National …
Development and use of active clinical decision support for preemptive pharmacogenomics
GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ...
Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014
Mandates: US National Institutes of Health
Patient safety culture and the second victim phenomenon: connecting culture to staff distress in nurses
RR Quillivan, JD Burlison, EK Browne, SD Scott, JM Hoffman
The Joint Commission Journal on Quality and Patient Safety 42 (8), 377-AP2, 2016
Mandates: US National Institutes of Health
The effects of the second victim phenomenon on work-related outcomes: connecting self-reported caregiver distress to turnover intentions and absenteeism
JD Burlison, RR Quillivan, SD Scott, S Johnson, JM Hoffman
Journal of Patient Safety 17 (3), 195-199, 2021
Mandates: US National Institutes of Health
Development and implementation of a pharmacist-managed clinical pharmacogenetics service
KR Crews, SJ Cross, JN McCormick, DK Baker, AR Molinelli, R Mullins, ...
American Journal of Health-System Pharmacy 68 (2), 143-150, 2011
Mandates: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing: 2014 Update
MA Martin, JM Hoffman, RR Freimuth, TE Klein, BJ Dong, M Pirmohamed, ...
Clinical Pharmacology & Therapeutics 95 (5), 499-500, 2014
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Integrating pharmacogenomics into electronic health records with clinical decision support
JK Hicks, HM Dunnenberger, KF Gumpper, CE Haidar, JM Hoffman
American journal of health-system pharmacy 73 (23), 1967-1976, 2016
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program